PALO ALTO, CA--(Marketwire - April 16, 2012) - AirXpanders Inc., a company developing technology to address current unmet needs for patients who require tissue expansion for breast reconstruction surgery, today announced that it has expanded its senior management team with new hires to help the company prepare for a successful launch of AeroForm in early 2013.
"We are honored to attract such exceptionally talented, experienced, and successful professionals to AirXpanders to complement our growing leadership team as we prepare for a potential U.S. launch of AeroForm early next year," says Scott Dodson, President and CEO of AirXpanders. "Enrollment in the pivotal XPAND study of our AeroForm tissue expansion device in mastectomy patients going through breast reconstruction is on track. As the study continues, we are working diligently to prepare our regulatory submission to the FDA and ensure that we have the proper quality systems in place for a successful commercial rollout. These high caliber team members will play a crucial part in the growth and expansion of our company and will add to our commitment to quality and excellence."
Naghmeh Nouri has been named Senior Director of Quality and Regulatory, John Lai joins the company as Director of Finance, and Tony Morefield joins AirXpanders as Senior Director of Operations.
Nouri joins AirXpanders with 28 years of experience as a scientist and quality expert. She was previously VP of Quality and Regulatory at Asante Solutions and VP of Quality and Regulatory at Health Hero Network where she led all activities for quality and regulatory implementation, product maintenance, and secured a CE Mark, 510K and managed a new series of FDA regulations. Nouri holds both an M.S. and a B.S. from the Rutgers Electrical Engineering Honors Program.
Lai, a seasoned financial services professional, joins AirXpanders after 14 years of experience in the field of accounting and finance. Previously, John served as Director of Accounting and Finance Services for Montgomery Professional Services and is an expert in financial services for medical device companies. John holds a B.A. in Accounting from Seattle University.
Morefield has over 15 years of experience in the medical device and aerospace industry with a focus on transitioning innovative technologies through late stage development into full scale manufacturing. He most recently held the position of Senior Director of Manufacturing and Engineering at Avantis Medical Systems where he was responsible for ramping operations during the course of clinical studies and into full commercialization with the eventual transition into off-shore manufacturing. Morefield holds a B.S. from the University of Oregon.
AirXpanders Inc. (www.airxpanders.com), is a tissue-expansion company focused on the area of breast cancer reconstruction. By employing a revolutionary patient-controlled expander, activated by a wireless remote control, the often painful process of recovering one's feminine shape after cancer can potentially be eased with this needle-free technology that is easy to use and may enable the patient to proceed to a permanent implant much faster than the current standard-of-care. At this time, AirXpanders' products are not cleared or approved for sale. AirXpanders is backed by Vivo Ventures, GBS Venture Partners, Prolog Ventures, Heron Capital and Shalon Ventures.